TATAA Biocenter

TATAA Biocenter is a specialized, full-service CRO offering high-precision molecular bioanalytical services for the biopharmaceutical industry. With over two decades of experience, the company has established itself as a leader in PCR innovation and bioanalysis for advanced therapies, contributing to industry guidelines and hundreds of publications. Its core value proposition lies in providing regulatory-compliant, customized assay development, validation, and sample analysis, leveraging a team of over 40 scientists and state-of-the-art automated infrastructure. TATAA operates as a key partner for companies developing complex nucleic acid-based therapeutics.

Integrated molecular and proteomic analysis platform featuring qPCR, dPCR, NGS (RNA-Seq, DNA-Seq, immune repertoire), Olink and Illumina proteomics, automated sample prep, and custom assay development/validation compliant with GLP/GCLP.

Competes with large, full-service global CROs (e.g., LabCorp, IQVIA) that offer molecular services, and with specialized niche molecular and genomic CROs (e.g., Eurofins, Charles River's specific units). Differentiation is based on deep PCR/NGS expertise, regulatory leadership in advanced therapy bioanalysis, and a focused client-partnership model.